InvestorsHub Logo

Lemoncat

01/24/21 9:41 PM

#341373 RE: DaubersUP #341370

2) Kevetrin - Phase 2 Successful (Ovarian)



Well....I don't know that we can call that successful. We declared victory after two patients and then ended the trial.

3) Prurisol - Phase 2a Successful (Mild - Moderate Psoriasis)



This one was a staggering failure because it gave us a false positive and plunged us into a trial failure from which we lost an entire drug, lots of money, and lots of credibility with how the interim and final results reporting was handled. Prurisol tanked the company harder than Mako.

5) B-OM - Phase 2 Successful (Oral Mucositis - PREVENTION) Leader in an untapped market



The first half of this trial (interim report) was stupendously good. The second half was a disaster. This is probably why we can't partner it for decent money.

Go IPIX!

wsbc

01/24/21 11:36 PM

#341377 RE: DaubersUP #341370

Funny... this is the question I've literally been asking him for YEARS now, and he has no answer.

I wonder why that is...

This pipeline is phenomenal. Billions and in late stages across board. So the big question. WHY can’t Leo ink a deal. That is the question we all should be asking him daily. The drugs are too powerful on paper to screw this up. IMO.